MAP2K7 and pulmonary hypertension: This may promote hyperplasia and/or hypertrophy of the pulmonary vasculature in humans as MEK phosphorylation has been associated with de-differentiation, nuclear activation and proliferation of pulmonary vascular smooth muscle cells in pulmonary hypertension (Xing et al., 2019; Suzuki et al., 2021).